**Why it matters:**
The article discusses the importance of including experienced practitioners in the field of psychedelic therapy as Europe considers incorporating these treatments into its healthcare system. A lobby group called PAREA is advocating for the inclusion of seasoned professionals as members of a multidisciplinary advisory body, which would provide valuable insights to regulators and healthcare practitioners.
**What they are saying:**
PAREA argues that individuals with direct experience with psychedelics can offer better guidance than those who are solely motivated by financial gain. The lobby group wants to ensure that the implementation of psychedelic therapy is made easier by having an advisory board that includes people with personal experience with these substances.
**The big picture:**
Australia and parts of the United States have already authorized the use of psychedelics for therapeutic purposes. As Europe prepares for potential legalization, lawmakers want to be ready to implement these treatments effectively. Having an advisory board with individuals who understand and have experience with psychedelics would help provide centralized leadership and standardized care for these therapies.
**What to watch:**
It will be important to monitor how Europe progresses in legalizing and integrating psychedelic treatments into its healthcare system. The formation of a multidisciplinary advisory body that includes experienced practitioners would be a significant step towards establishing evidence-based and patient-centric psychedelic therapy.
**My take:**
Including individuals with firsthand experience with psychedelics in the development and regulation of these therapies is crucial. Their insights and expertise can contribute to the safe and effective implementation of psychedelic treatments. By establishing a multidisciplinary advisory body, Europe can ensure consistency and standardization in the delivery of these therapies, ultimately benefiting patients seeking alternative mental health treatments. The growing recognition of psychedelics in academia, such as the launch of a free online course on the subject, further indicates the increasing acceptance and interest in this field.
